Migraine Disability Assessment (MIDAS)
The Migraine Disability Assessment (MIDAS) quantifies headache‑related functional disability over the prior three months 1 [Level III evidence].
Indications for Use
Used to quantify migraine-related functional disability over 3 months to guide treatment intensity and monitor response. Indicated for episodic or chronic migraine when assessing impact on work, household tasks, and social activities. Clinically useful due to high reliability (test–retest r≈0.8) and validated correlation with diary‑based disability 1 [Level I evidence]. A standard secondary outcome in trials and practice guidelines for tracking disability change 2 [Level I evidence].
Insights & Cautions
Quantifies migraine‑related lost days and correlates well with diary‑based disability (r≈0.63) and physician judgment 1 [Level I evidence]. Reliable across populations (test–retest ≈0.8) 2 [Level I evidence]. Limited by recall bias, modest responsiveness to change—especially in high‑frequency/chronic migraine 3 [Level II evidence]. Less sensitive for short‑term effects and may show intra‑individual variability over repeated use.